Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ι/Π Study of Human Cord Blood Mononuclear Cells and Human Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Hormone Replacement Therapy in Patients With Premature Ovarian Failure

NCT01742533 is registered in ClinicalTrials.gov with Shenzhen Beike Bio-Technology Co., Ltd. as lead sponsor.

NCT NCT01742533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01742533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ι/Π Study of Human Cord Blood Mononuclear Cells and Human Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Hormone Replacement Therapy in Patients With Premature Ovarian Failure
Lead sponsor
Shenzhen Beike Bio-Technology Co., Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2012
Completion date
March 31, 2014
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premature ovarian failure，